Bio-Rad Laboratories (BIO) Receives FDA Clearance for 2 New Multiplex Infectious Disease Serology Panels
More News related to BIO
- BioAlliance Pharma: Epidemiological study on Oropharyngeal Candidiasis and results on miconazole MBT* compliance were presented at the 51st ASTRO Annual Meeting
- BioAlliance Pharma Presents Additional US Pivotal Phase III Results on Loramyc(TM) (Miconazole Lauriad(R)) at the 47Th Annual Meeting of the IDSA
- After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
- Bio-Rad (BIO) Posts Q3 EPS of $1.38, Tops Estimates
- Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 11 Percent
More News related to Corporate News
- Reports Moody's said AIG (AIG) may be able to repay the U.S.
- Force Protection (FRPT) Nearly Doubles EPS Views
- Fluor Corporation (FLR) Posts Q3 EPS of $0.89, Misses by 1c; Guides FY09 and FY10
- Electronic Arts (ERTS) Misses Q3 EPS by 1c; Guide In-Line
- Google (GOOG) to acquire AdMob for $750M in stock
Bio-Rad Laboratories, Inc. (NYSE: BIO) announced the FDA clearance of two new multiplex infectious disease serology panels for use on the BioPlex 2200 system: the BioPlex ToRC IgG panel and the BioPlex HSV-1 & HSV-2 IgG panel. The BioPlex 2200 system is a fully automated, random access platform that employs multiplexing technology to analyze multiple disease markers from a single patient sample.
The ToRC IgG kit simultaneously detects IgG class antibodies to Toxoplasma gondii (T. gondii), Rubella, and Cytomegalovirus (CMV). T. gondii, Rubella, and CMV can cause a variety of serious conditions in an unborn fetus including blindness, retardation, and death. The HSV-1 & HSV-2 IgG kit utilizes type-specific proteins to simultaneously detect and differentiate IgG class antibodies to the two most common herpes subtypes, HSV-1 and HSV-2. The ToRC IgG kit is available for sale and the HSV kit is pending launch.
Bio-Rad Laboratories, Inc. (Bio-Rad) manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.[SM]
Related Categories
Corporate NewsFDA
Stocks Mentioned
+1.17Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
